astatine has been researched along with Prostatic-Neoplasms--Castration-Resistant* in 1 studies
1 review(s) available for astatine and Prostatic-Neoplasms--Castration-Resistant
| Article | Year |
|---|---|
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.
To summarise data with radium-223 dichloride (. Literature for this systematic review was identified using a PubMed search: ("targeted alpha therapy" or "targeted alpha particle therapy") or (213-bismuth or bismuth-213 or 213Bi) or (225-actinium or actinium-225 or 225Ac) or (211-astatine or astatine-211 or 211At) or (212-lead or lead-212 or 212Pb) or (227-thorium or thorium-227 or 227Th) or (223-radium or radium-223 or 223Ra or alpharadin) and (malignancy or cancer). Results were limited to English-language publications in humans, with the article type "clinical trial".. Forty-one publications were included (30 from the literature search and 11 from manual searches/reviews). In clinical trials in mCRPC, Topics: Actinium; Astatine; Bismuth; Bone Neoplasms; Humans; Lead Radioisotopes; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Thorium | 2020 |